Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 72626 - 72650 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	RNASEL	6041	upregulated	Silicon Dioxide results in increased expression of RNASEL mRNA	1q25.3	A24196
Silicon dioxide	Approved	RND1	27289	downregulated	Silicon Dioxide analog results in decreased expression of RND1 mRNA	12q13.12	A24195
Silicon dioxide	Approved	RND1	27289	upregulated	Silicon Dioxide results in increased expression of RND1 mRNA	12q13.12	A24196
Silicon dioxide	Approved	RND3	390	upregulated	Silicon Dioxide analog results in increased expression of RND3 mRNA	2q23.3	A24195
Silicon dioxide	Approved	RNF103	7844	downregulated	Silicon Dioxide analog results in decreased expression of RNF103 mRNA	2p11.2	A24195
Silicon dioxide	Approved	RNF112	7732	downregulated	Silicon Dioxide analog results in decreased expression of RNF112 mRNA	17p11.2	A24195
Silicon dioxide	Approved	RNF112	7732	upregulated	Silicon Dioxide analog results in increased expression of RNF112 mRNA	17p11.2	A24194
Silicon dioxide	Approved	RNF13	11342	downregulated	Silicon Dioxide results in decreased expression of RNF13 mRNA	3q25.1	A24196
Silicon dioxide	Approved	RNF144B	255488	downregulated	Silicon Dioxide analog results in decreased expression of RNF144B mRNA	6p22.3	A24195
Silicon dioxide	Approved	RNF145	153830	upregulated	Silicon Dioxide analog results in increased expression of RNF145 mRNA	5q33.3	A24194
Silicon dioxide	Approved	RNF150	57484	downregulated	Silicon Dioxide analog results in decreased expression of RNF150 mRNA	4q31.21	A24195
Silicon dioxide	Approved	RNF150	57484	upregulated	Silicon Dioxide analog results in increased expression of RNF150 mRNA	4q31.21	A24194
Silicon dioxide	Approved	RNF17	56163	downregulated	Silicon Dioxide analog results in decreased expression of RNF17 mRNA	13q12.12	A24195
Silicon dioxide	Approved	RNF170	81790	downregulated	Silicon Dioxide results in decreased expression of RNF170 mRNA	8p11.21	A24196
Silicon dioxide	Approved	RNF182	221687	upregulated	Silicon Dioxide analog results in increased expression of RNF182 mRNA	6p23	A24195
Silicon dioxide	Approved	RNF19A	25897	downregulated	Silicon Dioxide analog results in decreased expression of RNF19A mRNA	8q22.2	A24195
Silicon dioxide	Approved	RNF19B	127544	upregulated	Silicon Dioxide analog results in increased expression of RNF19B mRNA	1p35.1	A24195
Silicon dioxide	Approved	RNF39	80352	upregulated	Silicon Dioxide results in increased expression of RNF39 mRNA	6p22.1	A24197 A24196
Silicon dioxide	Approved	RNF41	10193	downregulated	Silicon Dioxide results in decreased expression of RNF41 mRNA	12q13.3	A24196
Silicon dioxide	Approved	RNF5	6048	downregulated	Silicon Dioxide analog results in decreased expression of RNF5 mRNA	6p21.32	A24195
Silicon dioxide	Approved	RNF6	6049	upregulated	Silicon Dioxide analog results in increased expression of RNF6 mRNA	13q12.13	A24194
Silicon dioxide	Approved	RNF6	6049	upregulated	Silicon Dioxide results in increased expression of RNF6 mRNA	13q12.13	A24196
Silicon dioxide	Approved	ROCK1	6093	upregulated	Silicon Dioxide analog results in increased expression of ROCK1 mRNA	18q11.1	A24195
Silicon dioxide	Approved	ROR1	4919	upregulated	Silicon Dioxide analog results in increased expression of ROR1 mRNA	1p31.3	A24195
Silicon dioxide	Approved	RP9	6100	upregulated	Silicon Dioxide analog results in increased expression of RP9 mRNA	7p14.3	A24195

Displaying entries 72626 - 72650 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability